Multifunctional Bi2WO6 Nanoparticles for CT-Guided Photothermal and Oxygen-free Photodynamic Therapy
Source abstract
Abstract
The consumption of oxygen in photodynamic therapy (PDT) significantly exacerbates the degree of hypoxia in tumors, which not only impedes the therapeutic effect of PDT, but also drives local tumor recurrence. To relieve the PDT-induced hypoxia and improve the therapeutic outcome of PDT in cancer treatment, herein we reported a class of Bi 2 WO 6 nanoparticles (NPs) as a robust multifunctional platform, which integrates the abilities for contrast-enhanced computed tomography (CT) imaging, photothermal therapy, and PDT in an oxygen-free manner. The as-obtained Bi 2 WO 6 NPs with a mean diameter of 5.2 nm are stable in phosphate-buffered saline and an in vivo microenvironment-mimicking buffer. The location of the solid tumor could be accurately positioned using Bi 2 WO 6 -enhanced CT with higher spatial resolution. After being irradiated with an 808 nm laser, these Bi 2 WO 6 NPs could realize CT-guided local photothermal ablation of the tumor. Meanwhile, • OH radicals were generated simultaneously from the treatment without consuming an oxygen molecule, which enabled these Bi 2 WO 6 NPs to exert photodynamic killing effect in an oxygen-free manner during cancer therapy. Remarkable tumor suppression was observed in mice bearing the HeLa xenograft, supporting the promising application of these multifunctional Bi 2 WO 6 NPs in the combat against cancers through synergistic photothermal and oxygen-free PDT treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Photoacoustic and Ultrasonic Imaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing 210008, China
Funding
Ministry of Science and Technology of the People's Republic of China · Government of Jiangsu Province · National Natural Science Foundation of China · Medical Science and Technology Development Foundation, Nanjing Department of Health
References (48)
Show source-provided references
1. 10.1152/physrev.00038.201010.1152/physrev.00038.2010 ↗
2. 10.1158/1078-0432.CCR-09-144810.1158/1078-0432.CCR-09-1448 ↗
3. 10.1038/nrclinonc.2012.127-c110.1038/nrclinonc.2012.127-c1 ↗
4. 10.1038/nrc234410.1038/nrc2344 ↗
5. 10.1007/s10555-007-9055-110.1007/s10555-007-9055-1 ↗
6. 10.1016/j.bbamcr.2015.05.03610.1016/j.bbamcr.2015.05.036 ↗
7. Brown J. M. · Cancer Res. · 1998 · 58 · 1408
8. 10.1158/0008-5472.CAN-12-012210.1158/0008-5472.CAN-12-0122 ↗
9. 10.1038/nrc395810.1038/nrc3958 ↗
10. 10.1002/adfm.20150272810.1002/adfm.201502728 ↗
11. 10.1021/acsami.6b1025510.1021/acsami.6b10255 ↗
12. 10.1021/acsnano.6b0307410.1021/acsnano.6b03074 ↗
13. 10.1021/acsami.7b0576610.1021/acsami.7b05766 ↗
14. 10.1021/acsami.5b0576310.1021/acsami.5b05763 ↗
15. 10.1021/am501608c10.1021/am501608c ↗
16. 10.1002/adma.20150586910.1002/adma.201505869 ↗
17. 10.1002/anie.20161178310.1002/anie.201611783 ↗
18. 10.1021/acsnano.6b0752510.1021/acsnano.6b07525 ↗
19. 10.1021/cr400532z10.1021/cr400532z ↗
20. 10.1021/acs.nanolett.6b0236510.1021/acs.nanolett.6b02365 ↗
21. 10.1038/srep2339310.1038/srep23393 ↗
22. 10.1038/ncomms978510.1038/ncomms9785 ↗
23. 10.1002/adfm.20160067610.1002/adfm.201600676 ↗
24. 10.1002/adma.20150461710.1002/adma.201504617 ↗
25. 10.1021/nn405773r10.1021/nn405773r ↗
26. 10.1021/acsnano.6b0415610.1021/acsnano.6b04156 ↗
27. 10.1016/j.apcatb.2013.08.03810.1016/j.apcatb.2013.08.038 ↗
28. 10.1002/anie.20130735810.1002/anie.201307358 ↗
29. 10.1002/adma.20160415710.1002/adma.201604157 ↗
30. 10.1039/c3nr05455a10.1039/c3nr05455a ↗
31. 10.1016/j.biomaterials.2015.08.00810.1016/j.biomaterials.2015.08.008 ↗
32. 10.1016/j.biomaterials.2015.04.00510.1016/j.biomaterials.2015.04.005 ↗
33. 10.1021/ja207150n10.1021/ja207150n ↗
34. 10.1002/anie.20090721010.1002/anie.200907210 ↗
35. 10.1038/ncomms934010.1038/ncomms9340 ↗
36. 10.1002/adma.20110328910.1002/adma.201103289 ↗
37. 10.1039/c3nr06292a10.1039/c3nr06292a ↗
38. 10.1039/C6RA28161C10.1039/C6RA28161C ↗
39. 10.1016/j.jep.2017.06.03710.1016/j.jep.2017.06.037 ↗
40. 10.1002/adma.20130201410.1002/adma.201302014 ↗
41. 10.1021/acsami.6b1335110.1021/acsami.6b13351 ↗
42. 10.1016/j.actbio.2017.06.02610.1016/j.actbio.2017.06.026 ↗
43. 10.1016/j.biomaterials.2014.07.03410.1016/j.biomaterials.2014.07.034 ↗
44. 10.1016/j.biomaterials.2011.10.05210.1016/j.biomaterials.2011.10.052 ↗
45. 10.1021/nn406258m10.1021/nn406258m ↗
46. 10.1073/pnas.101838210810.1073/pnas.1018382108 ↗
47. 10.1002/smll.20160272210.1002/smll.201602722 ↗
48. 10.1021/ja511420n10.1021/ja511420n ↗